Hypertrophic pulmonary osteoarthropathy: control of pain and symptoms with pamidronate

被引：26
作者：
Amital, H
Applbaum, YH
Vasiliev, L
Rubinow, A
机构：
[1] Hadassah Hebrew Univ Sch Med, Dept Radiol, Rheumatol Unit, IL-91120 Jerusalem, Israel
[2] Hadassah Hebrew Univ Sch Med, Div Internal Med, IL-91120 Jerusalem, Israel
来源：
CLINICAL RHEUMATOLOGY | 2004年 / 23卷 / 04期
关键词：
bisphosphonates; cyanotic heart disease; hypertrophic pulmonary osteoarthropathy; pain; pamidronate;
D O I：
10.1007/s10067-004-0941-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This case presents a patient with hypertrophic osteoarthropathy of the lower extremities that developed secondary to congenital cyanotic heart disease. The major clinical manifestation was severe bilateral leg pain. The pain that was debilitating in nature completely resolved following a single administration of 60 mg pamidronate. Hypertrophic osteoarthropathy (HOA) is an acquired, uncommon disorder of obscure etiology. It has been described mainly in association with chronic suppurative pulmonary diseases, bronchogenic carcinoma and lung metastases, cystic fibrosis, and cyanotic congenital malformations of the heart.
引用
收藏
页码：330 / 332
页数：3
相关论文
共 11 条
[1]  
Abe Y, 2002, ANTICANCER RES, V22, P3485
[2]   Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosis [J].
Garske, LA ;
Bell, SC .
CHEST, 2002, 121 (04) :1363-1364
[3]   Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras [J].
Luckman, SP ;
Hughes, DE ;
Coxon, FP ;
Russell, RGG ;
Rogers, MJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (04) :581-589
[4]  
MARTINEZLAVIN M, 1992, CLIN EXP RHEUMATOL, V10, P19
[5]  
PINEDA C, 1990, J RHEUMATOL, V17, P626
[6]   Bisphosphonates: new indications and methods of administration [J].
Reid, IR .
CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (04) :458-463
[7]   GENERALIZED HYPERTROPHIC OSTEOARTHROPATHY IN ASSOCIATION WITH BRONCHIAL CARCINOMA - A REVIEW, BASED ON 24 CASES [J].
SEMPLE, T ;
MCCLUSKIE, RA .
BMJ-BRITISH MEDICAL JOURNAL, 1955, 1 (MAR26) :754-759
[8]  
Silveira LH, 2000, CLIN EXP RHEUMATOL, V18, P57
[9]   Hypertrophic osteoarthropathy: Endothelium and platelet function [J].
Silveri, F ;
DeAngelis, R ;
Argentati, F ;
Brecciaroli, D ;
Muti, S ;
Cervini, C .
CLINICAL RHEUMATOLOGY, 1996, 15 (05) :435-439
[10]   Pamidronate-induced remission of pain associated with hypertrophic pulmonary osteoarthropathy in chemoendocrine therapy-refractory inoperable metastatic breast carcinoma [J].
Suzuma, T ;
Sakurai, T ;
Yoshimura, G ;
Umemura, T ;
Tamaki, T ;
Yoshimasu, T ;
Naito, Y .
ANTI-CANCER DRUGS, 2001, 12 (09) :731-734
12